Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Acute MI Workup in Emergency Departments Varies by Sex and Race

Michael O'Riordan

May 11, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

Advertisement

Heart Disease Treatment Costs $100 Billion per Year in the US

Think You Need a Statin? AHA’s Risk Calculator May Disagree

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

April 2024 Dispatch for the CV Team

Mortality Risk Varies Among Patients With Very High LDL Levels

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

CABG and PCI Comparable in ACS Patients With Left Main CAD

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Acute MI Workup in Emergency Departments Varies by Sex and Race

Good News and Bad for High-Intensity Statin Use in ASCVD

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

Food Insecurity Common Among Patients With ASCVD

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content